Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Perazella

Showing results (131-140 of 278) with videos related to

Pageof 28
Sort By:
Expert Opinion on Drug Safety|March 8, 2008
Drug-induced crystal nephropathy: an updateSri G Yarlagadda, Mark A Perazella
The American Journal of Medicine|September 2, 2006
An odd case of hypertensionJohn E Aruny, Mark A Perazella
The American Journal of Medicine|February 6, 2007
Diagnostic and therapeutic approach to acute decompensated heart failureJohn R Kapoor, Mark A Perazella
Journal of Hospital Medicine|January 12, 2010
Nephrogenic systemic fibrosis: what the hospitalist needs to knowDerek M Fine, Mark A Perazella
Kidney International|April 1, 2015
Shocking urineBarry R Gorlitsky, Mark A Perazella
The American Journal of Medicine|August 7, 2007
Prevention of contrast-induced nephropathy in high-risk patients with hemofiltrationSteven G Coca, Mark A Perazella
Journal of Nephrology|April 14, 2016
PPIs and kidney disease: from AIN to CKDDennis G Moledina, Mark A Perazella
The New England Journal of Medicine|August 3, 2017
Acute Kidney Injury in Patients with CancerMitchell H Rosner, Mark A Perazella
Oncology (Williston Park, N.Y.)|August 7, 2018
Acute Kidney Injury in Patients With CancerMark A Perazella, Mitchell H Rosner
Clinical Journal of the American Society of Nephrology : CJASN|April 18, 2018
Introduction to Nephropharmacology for the Clinician: A New <i>CJASN</i> SeriesThomas D Nolin, Mark A Perazella
Pageof 28

Showing results (131-140 of 278) with videos related to

Sort By:
Pageof 28
Expert Opinion on Drug Safety|March 8, 2008
Drug-induced crystal nephropathy: an updateSri G Yarlagadda, Mark A Perazella
The American Journal of Medicine|September 2, 2006
An odd case of hypertensionJohn E Aruny, Mark A Perazella
The American Journal of Medicine|February 6, 2007
Diagnostic and therapeutic approach to acute decompensated heart failureJohn R Kapoor, Mark A Perazella
Journal of Hospital Medicine|January 12, 2010
Nephrogenic systemic fibrosis: what the hospitalist needs to knowDerek M Fine, Mark A Perazella
Kidney International|April 1, 2015
Shocking urineBarry R Gorlitsky, Mark A Perazella
The American Journal of Medicine|August 7, 2007
Prevention of contrast-induced nephropathy in high-risk patients with hemofiltrationSteven G Coca, Mark A Perazella
Journal of Nephrology|April 14, 2016
PPIs and kidney disease: from AIN to CKDDennis G Moledina, Mark A Perazella
The New England Journal of Medicine|August 3, 2017
Acute Kidney Injury in Patients with CancerMitchell H Rosner, Mark A Perazella
Oncology (Williston Park, N.Y.)|August 7, 2018
Acute Kidney Injury in Patients With CancerMark A Perazella, Mitchell H Rosner
Clinical Journal of the American Society of Nephrology : CJASN|April 18, 2018
Introduction to Nephropharmacology for the Clinician: A New <i>CJASN</i> SeriesThomas D Nolin, Mark A Perazella
Pageof 28